Trends in Low-Density Lipoproteins Cholesterol (LDL-C) in US Aged 12 to 80 Years: Data from the 2007-2018 National Health and Nutrition Examination Survey (NHANES)
DOI:
https://doi.org/10.12974/2309-6179.2022.07.03Keywords:
Serum lipids, Aging, lipoprotein ratio, Cholesterol, Cardiovascular diseasesAbstract
Background: Elevated levels of low-density lipoprotein cholesterol (LDL-C) are associated with an increased risk of coronary heart disease.
Objectives: We described LDL-C distributions across the age span and compared the trends in three distinct cross-sectional surveys during 2007-2010, 2011-2014, and 2015-2018.
Methods: This is an observational study. Blood lipid measurements, taken from 40,977 noninstitutionalized participants, aged 12 to 80, were obtained from the National Health and Nutrition Examination Survey (NHANES) study.
Results: The LDL-C values changed by age and differed by sex. Mean LDL-C levels increased with age through middle age and then decreased with age. In males, mean LDL-C declined from 104.5 (95% CI, 103.6-105.3) in 2007-2010, to 100.5 (95% CI, 99.7-101.4) in 2011-2014, and 100.8 (95% CI, 99.9-101.7) in 2015-2018 (p<0.001 for linear trend). In females, mean LDL-C declined from 110.3 (95% CI, 109.5-111.1) in 2007-2010, to 108.3 (95% CI, 107.6-109.1) in 2011-2014, and 106.8 (95% CI, 105.9-107.7) in 2015-2018 (p<0.001 for linear trend).
Conclusions: Between 2007 and 2018, favorable trends in LDL-C levels were observed among noninstitutionalized residents in the US.
References
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020 Dec 22; 76(25): 2982-3021.
Li Z, Lin L, Wu H, Yan L, Wang H, Yang H, et al. Global, Regional, and National Death, and Disability-Adjusted LifeYears (DALYs) for Cardiovascular Disease in 2017 and Trends and Risk Analysis From 1990 to 2017 Using the Global Burden of Disease Study and Implications for Prevention. Front Public Health. 2021; 9: 559751. https://doi.org/10.3389/fpubh.2021.559751
Mensah GA, Brown DW. An overview of cardiovascular disease burden in the United States. Health Aff Proj Hope. 2007 Feb; 26(1): 38-48. https://doi.org/10.1377/hlthaff.26.1.38
Arnett DK, Blumenthal RS, Albert MA, Michos ED, Buroker AB, Miedema MD, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary. Circulation. 2019 Sep 10; 140(11): e563-95. https://doi.org/10.1161/CIR.0000000000000677
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016 Aug 1; 37(29): 2315-81. https://doi.org/10.1093/eurheartj/ehw106
Broedl UC, Geiss HC, Parhofer KG. Comparison of Current Guidelines for Primary Prevention of Coronary Heart Disease. J Gen Intern Med. 2003 Mar; 18(3): 190-5. https://doi.org/10.1046/j.1525-1497.2003.20207.x
Ferhatbegov ic L, Mršic D, Kušljugic S, Pojskic B. LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated? Curr Atheroscler Rep. 2022 May 28; https://doi.org/10.1007/s11883-022-01037-3
Gluckman TJ, Kovacs RJ, Stone NJ, Damalas D, Mullen JB, Oetgen WJ. The ASCVD Risk Estimator App: From Concept to the Current State. J Am Coll Cardiol. 2016 Jan 26; 67(3): 350-2. https://doi.org/10.1016/j.jacc.2015.10.068
Surguchov AP, Page GP, Smith L, Patsch W, Boerwinkle E. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 1996 Aug; 16(8): 941-7. https://doi.org/10.1161/01.ATV.16.8.941
Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME. Trends in lipids and lipoproteins in US adults, 1988-2010. JAMA. 2012 Oct 17; 308(15): 1545-54. https://doi.org/10.1001/jama.2012.13260
Kit BK, Carroll MD, Lacher DA, Sorlie PD, DeJesus JM, Ogden C. Trends in serum lipids among US youths aged 6 to 19 years, 1988-2010. JAMA. 2012 Aug 8; 308(6): 591-600. https://doi.org/10.1001/jama.2012.9136
Carroll MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA. 2005 Oct 12; 294(14): 1773-81. https://doi.org/10.1001/jama.294.14.1773
Perak AM, Ning H, Kit BK, de Ferranti SD, Van Horn LV, Wilkins JT, et al. Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999- 2016. JAMA. 2019 May 21; 321(19): 1895-905. https://doi.org/10.1001/jama.2019.4984
Byrne P, Demasi M, Jones M, Smith SM, O'Brien KK, DuBroff R. Evaluating the Association Between Low-Density Lipoprotein Cholesterol Reduction and Relative and Absolute Effects of Statin Treatment: A Systematic Review and Metaanalysis. JAMA Intern Med. 2022 May 1; 182(5): 474-81. https://doi.org/10.1001/jamainternmed.2022.0134
Liu K, Wilkins JT, Colangelo LA, Lloyd-Jones DM. Does Lowering Low-Density Lipoprotein Cholesterol With Statin Restore Low Risk in Middle-Aged Adults? Analysis of the Observational MESA Study. J Am Heart Assoc. 2021 Jun; 10(11): e019695. https://doi.org/10.1161/JAHA.120.019695
Ference BA, Yoo W, Alesh I, Mahajan N, Mirowska KK, Mewada A, et al. Effect of long-term exposure to lower lowdensity lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol. 2012 Dec 25; 60(25): 2631-9. https://doi.org/10.1016/j.jacc.2012.09.017
Dansethakul P, Thapanathamchai L, Saichanma S, Worachartcheewan A, Pidetcha P. Determining a new formula for calculating low-density lipoprotein cholesterol: data mining approach. EXCLI J. 2015 Mar 26; 14: 478-83.
Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kw iterovich PO, Blumenthal RS, et al. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013 Nov 20; 310(19): 2061-8. https://doi.org/10.1001/jama.2013.280532
Swiger KJ, Martin SS, Blaha MJ, Toth PP, Nasir K, Michos ED, et al. Narrowing sex differences in lipoprotein cholesterol subclasses following mid-life: the very large database of lipids (VLDL-10B). J Am Heart Assoc. 2014 Apr 22; 3(2): e000851. https://doi.org/10.1161/JAHA.114.000851
Abu-Farha M, Thanaraj TA, Qaddoumi MG, Hashem A, Abubaker J, Al-Mulla F. The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target. Int J Mol Sci. 2020 May 17; 21(10): 3544. https://doi.org/10.3390/ijms21103544
Surma S, Banach M, Lewek J. COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection. Lipids Health Dis. 2021 Oct 25; 20(1): 141. https://doi.org/10.1186/s12944-021-01563-0
Li Y, Zhang Y, Lu R, Dai M, Shen M, Zhang J, et al. Lipid metabolism changes in patients with severe COVID-19. Clin Chim Acta Int J Clin Chem. 2021 Jun; 517: 66-73. https://doi.org/10.1016/j.cca.2021.02.011
Wang G, Zhang Q, Zhao X, Dong H, Wu C, Wu F, et al. Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study. Lipids Health Dis. 2020 Sep 7; 19(1): 204. https://doi.org/10.1186/s12944-020-01382-9
Yue J, Xu H, Zhou Y, Liu W, Han X, Mao Q, et al. Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study. Front Endocrinol. 2021; 12: 611526. https://doi.org/10.3389/fendo.2021.611526
Fan J, Wang H, Ye G, Cao X, Xu X, Tan W, et al. Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism. 2020 Jun; 107: 154243. https://doi.org/10.1016/j.metabol.2020.154243
